Dermatomyositis
📧 Sign up to get email alerts when something new happens for Dermatomyositis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-08-25Clinical Trial Results: A Phase 2 Proof of Concept Study to Evaluate the Efficacy and Safety of Daxdilimab in Participants With Dermatomyositis (DM) or Anti-synthetase Inflammatory Myositis (ASIM) [Phase 2]
Phase 2 proof-of-concept study evaluating the efficacy and safety of Daxdilimab in dermatomyositis and anti-synthetase inflammatory myositis…
-
CLINICAL_TRIALS trial_result · 2026-07-24Clinical Trial Update: A Study to Investigate the Efficacy and Safety of Efgartigimod PH20 SC in Adult Participants With Active Idiopathic Inflammatory Myopathy. [Phase 2, Phase 3]
A Phase 2/3 trial evaluating the efficacy and safety of Efgartigimod PH20 SC in adults with active idiopathic inflammatory myopathy has comp…
-
CLINICAL_TRIALS trial_result · 2026-07-17Clinical Trial Update: A Study to Investigate the Efficacy and Safety of Brepocitinib in Adults With Dermatomyositis [Phase 3]
Phase 3 trial update for brepocitinib in adults with dermatomyositis indicates ongoing investigation of efficacy and safety.
-
CLINICAL_TRIALS trial_result · 2026-04-27Clinical Trial Update: Safety and Efficacy of ULSC on Disease Severity and Steroid Tapering in Participants With Dermatomyositis/ Polymyositis (DM/PM), Also Known as Idiopathic Inflammatory Myopathy (IIM) [Phase 2, Phase 3]
A Phase 2/3 clinical trial update reports on safety and efficacy of ULSC for reducing disease severity and enabling steroid tapering in Derm…
-
CLINICAL_TRIALS trial_result · 2026-03-31Clinical Trial Update: Diagnostic Accuracy of Whole Body Magnetic Resonance Imaging in Inflammatory Myopathies [NA]
A completed clinical trial evaluating the diagnostic accuracy of whole-body magnetic resonance imaging for detecting inflammatory myopathies…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-03-23Clinical Trial Update: Muscle Function and Effects of Repetitive Task Training in Patients With Inflammatory Myopaties [NA]
This completed clinical trial evaluated muscle function and the effects of repetitive task training in patients with inflammatory myopathies…
-
CLINICAL_TRIALS trial_result · 2025-12-22Clinical Trial Update: Efficacy of an Individual Rehabilitation Program in Polymyositis and Dermatomyositis [Phase 2]
Phase 2 study evaluating an individual rehabilitation program for polymyositis and dermatomyositis has completed and reported efficacy resul…
-
CLINICAL_TRIALS trial_result · 2025-12-09Clinical Trial Update: A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of IgPro20 in Adults With Dermatomyositis (DM) [Phase 3]
A Phase 3 study evaluating IgPro20 for dermatomyositis in adults was terminated; results have been posted.
-
CLINICAL_TRIALS trial_result · 2025-11-03Clinical Trial Update: A Phase 2 Proof of Concept Study to Evaluate the Efficacy and Safety of Daxdilimab in Participants With Dermatomyositis (DM) or Anti-synthetase Inflammatory Myositis (ASIM) [Phase 2]
Amgen completed a Phase 2 proof-of-concept trial evaluating the efficacy and safety of Daxdilimab in Dermatomyositis and anti-synthetase inf…
-
CLINICAL_TRIALS trial_result · 2025-09-08Clinical Trial Update: Intralesional Injection of STS in Treatment of Calcinosis [Phase 2]
A Phase 2 clinical trial evaluating intralesional sodium thiosulfate for calcinosis associated with systemic sclerosis and other connective …
-
CLINICAL_TRIALS trial_result · 2025-05-20Clinical Trial Update: A 12-Week Open-Label Study to Investigate the Efficacy and Safety of Brepocitinib in Adults With Skin-Predominant Dermatomyositis [Phase 2]
A Phase 2 open-label study evaluating the efficacy and safety of brepocitinib in adults with skin-predominant dermatomyositis has completed.
-
CLINICAL_TRIALS trial_result · 2025-03-13Clinical Trial Update: Interest of LC-OCT for Diagnosing Inflammatory Dermatoses: ODIN (OCT Dermotoses INflammatoires)
ODIN is a completed clinical trial evaluating the use of LC-OCT to diagnose inflammatory dermatoses, assessing its potential diagnostic valu…
-
CLINICAL_TRIALS trial_result · 2025-02-21Clinical Trial Update: Evaluation of Tp-e Interval and Tp-e/QT Ratio in Dermatomyositis and Analysis of Their Relationship With Inflammation
The trial evaluated Tp-e interval and Tp-e/QT ratio in patients with dermatomyositis. It analyzed their relationship with inflammation and m…
-
CLINICAL_TRIALS trial_result · 2025-02-06Clinical Trial Update: An Extension Study for Participants Who Have Completed the Treatment Period of a Qualifying Parent Study [Phase 2]
An extension study for participants who completed the treatment period of a qualifying Phase 2 parent study in dermatomyositis has completed…
-
CLINICAL_TRIALS trial_result · 2025-01-24Clinical Trial Update: Phase 1 Study of ULSC in Patients With Polymyositis (PM) and Dermatomyositis (DM) [EARLY_Phase 1]
A Phase 1 study evaluating ULSC in patients with polymyositis and dermatomyositis has completed.
-
CLINICAL_TRIALS trial_result · 2024-12-13Clinical Trial Update: A Phase 1 Study of MEDI7734 in Type I Interferon-Mediated Autoimmune Diseases [Phase 1]
Amgen reported completion of a Phase 1 study of MEDI7734 in Type I interferon-mediated autoimmune diseases, including dermatomyositis, polym…
-
CLINICAL_TRIALS trial_result · 2024-12-06Clinical Trial Update: Ravulizumab Versus Placebo in Adult Participants With Dermatomyositis [Phase 2, Phase 3]
Phase 2/3 trial of ravulizumab versus placebo in adults with dermatomyositis was terminated, and results have been posted.
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Exercise Capacity of Patients with Dermatomyosis [NA]
This entry notes that a clinical trial examining exercise capacity in patients with dermatomyositis has been terminated at University Hospit…
-
CLINICAL_TRIALS trial_result · 2024-06-11Clinical Trial Update: Efficacy and Safety of H.P. Acthar Gel for the Treatment of Refractory Cutaneous Manifestations of Dermatomyositis [Phase 4]
A Phase 4 clinical trial update reports on the efficacy and safety of Acthar Gel (repository corticotropin injection) for refractory cutaneo…
-
CLINICAL_TRIALS trial_result · 2024-06-05Clinical Trial Update: Open-label Extension to the Phase 2 Crossover Study (PRESIDIO) Evaluating KZR-616 in Patients With PM and DM. [Phase 2]
Open-label extension results from the Phase 2 PRESIDIO crossover study evaluating KZR-616 in polymyositis and dermatomyositis have been comp…
-
CLINICAL_TRIALS trial_result · 2024-05-13Clinical Trial Update: A Study of Ustekinumab in Participants With Active Polymyositis and Dermatomyositis Who Have Not Adequately Responded to One or More Standard-of-care Treatments [Phase 3]
Phase 3 trial of ustekinumab in active polymyositis and dermatomyositis was terminated, with results posted on May 13, 2024.
-
CLINICAL_TRIALS trial_result · 2024-04-03Clinical Trial Update: Allogeneic Mitochondria (PN-101) Transplantation for Refractory Polymyositis or Dermatomyositis [Phase 1, Phase 2]
Clinical trial updates on allogeneic mitochondria (PN-101) transplantation for refractory polymyositis or dermatomyositis have completed Pha…
-
CLINICAL_TRIALS trial_result · 2024-02-26Clinical Trial Update: Sodium Thiosulfate for Treatment of Calcinosis Associated With Juvenile and Adult Dermatomyositis [Phase 2, Phase 3]
Clinical trial update reporting results for sodium thiosulfate in calcinosis associated with dermatomyositis, with Phase 2 and Phase 3 studi…
-
CLINICAL_TRIALS trial_result · 2024-01-03Clinical Trial Update: A Phase 2 Study of KZR-616 to Evaluate Safety and Efficacy in Patients With Active Polymyositis or Dermatomyositis [Phase 2]
KZR-616, an immunoproteasome inhibitor, was studied in a Phase 2 trial for active polymyositis and dermatomyositis by Kezar Life Sciences; t…
-
CLINICAL_TRIALS trial_result · 2023-09-14Clinical Trial Update: A Study In Adults With Moderate To Severe Dermatomyositis [Phase 2]
Phase 2 clinical trial in adults with moderate to severe dermatomyositis completed; results posted in 2023.